• Thumbnail for Myriad Genetics
    Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number...
    22 KB (2,093 words) - 19:01, 24 February 2024
  • Association for Molecular Pathology v. Myriad Genetics, Inc., 569 U.S. 576 (2013), was a Supreme Court case, which decided that "a naturally occurring...
    47 KB (5,601 words) - 06:05, 15 December 2023
  • Pathology v. Myriad Genetics lawsuit mentioned below. The patents expire, starting in 2014. Association for Molecular Pathology v. Myriad Genetics was a 2013...
    26 KB (2,977 words) - 20:32, 23 January 2024
  • Thumbnail for BRCA mutation
    patents owned or controlled by Myriad Genetics. Myriad's business model of exclusively offering the diagnostic test led to Myriad growing from being a startup...
    71 KB (8,894 words) - 16:26, 9 April 2024
  • Thumbnail for BRCA1
    patents owned or controlled by Myriad Genetics. Myriad's business model of offering the diagnostic test exclusively led from Myriad being a startup in 1994 to...
    124 KB (14,616 words) - 15:51, 26 April 2024
  • Thumbnail for BRCA2
    Pathology v. Myriad Genetics lawsuit. The patents begin to expire in 2014. Peter Meldrum, CEO of Myriad Genetics, has acknowledged that Myriad has "other...
    72 KB (7,828 words) - 14:11, 16 April 2024
  • Thumbnail for Balaji Srinivasan
    parents to screen for Mendelian diseases. Counsyl was acquired by Myriad Genetics for $375 million in 2018. In 2013, Srinivasan joined the venture capital...
    27 KB (2,053 words) - 05:22, 12 April 2024
  • Thumbnail for Complementary DNA
    US Supreme Court decision in Association for Molecular Pathology v. Myriad Genetics, Inc. As a compromise, the Court declared, that exons-only cDNA is...
    19 KB (2,275 words) - 19:34, 18 February 2024
  • for genomics and proteomics predictive cancer test products made by Myriad Genetics, Inc. In May 2002, Labcorp announced the acquisition of all outstanding...
    41 KB (4,105 words) - 03:56, 25 March 2024
  • John Nicholas ruled in the Federal Court of Australia in favour of a Myriad Genetics patent on the BRCA1 gene. This was a landmark ruling, affirming the...
    26 KB (2,978 words) - 13:34, 5 February 2024